Turqoz 28 Day Shortage: What Providers and Prescribers Need to Know in 2026

Updated:

March 13, 2026

Author:

Peter Daggett

Summarize this blog with AI:

A provider briefing on Turqoz 28 Day availability in 2026. Learn about supply challenges, prescribing implications, and tools to help patients.

Provider Briefing: Turqoz 28 Day Availability in 2026

If your patients have been reporting difficulty filling prescriptions for Turqoz 28 Day (norgestrel/ethinyl estradiol 0.3 mg/0.03 mg), you're hearing a real concern. While Turqoz is not in a formal FDA drug shortage, its status as a newer brand-name combined oral contraceptive with no generic equivalent creates persistent availability challenges at the pharmacy level.

This article provides a clinical and logistical overview for prescribers — including current supply status, prescribing considerations, cost and access information, and tools to improve patient outcomes.

Timeline: How We Got Here

Turqoz was brought to market by Lupin Pharmaceuticals as a combined oral contraceptive containing norgestrel 0.3 mg and ethinyl estradiol 0.03 mg in a standard 21/7 regimen (21 active tablets plus 7 placebo tablets).

As a newer entrant in a crowded oral contraceptive market, Turqoz faces the same distribution challenges common to recently launched brand-name medications:

  • Limited formulary placement — Many pharmacy benefit managers (PBMs) have not yet added Turqoz to preferred formularies
  • Low pharmacy stocking rates — Pharmacies order based on demand; with low initial prescription volume, many don't stock it
  • Single-source manufacturing — Lupin is the sole manufacturer, with no authorized generic alternatives

These factors combine to create a situation where the drug is technically available but functionally hard for patients to obtain.

Prescribing Implications

When prescribing Turqoz 28 Day, consider the following:

Therapeutic Equivalence

Turqoz uses norgestrel — a racemic mixture of levonorgestrel and dextronorgestrel — paired with ethinyl estradiol. While pharmacologically related to levonorgestrel-containing COCs, Turqoz is not AB-rated to any other oral contraceptive, meaning pharmacists cannot automatically substitute another product.

Patient Adherence Risk

Availability issues directly threaten contraceptive adherence. Patients who cannot fill their Turqoz prescription may:

  • Miss multiple days of active pills, increasing pregnancy risk
  • Discontinue hormonal contraception altogether
  • Self-switch to an over-the-counter method with lower efficacy

Proactive communication about backup options can mitigate these risks.

Switching Considerations

If a patient cannot obtain Turqoz, switching to another combined oral contraceptive is generally straightforward. Comparable options include:

  • Levonorgestrel/ethinyl estradiol combinations (e.g., Levlen, Nordette generics) — closest pharmacologic match
  • Norgestimate/ethinyl estradiol (Ortho-Cyclen, Sprintec) — widely available generics
  • Drospirenone/ethinyl estradiol (Yaz, Loryna) — also treats PMDD and acne
  • Lo Loestrin Fe — for patients who prefer ultra-low estrogen dosing

Instruct patients to start the new COC the day after their last active Turqoz tablet, or on the first day of their next menses. Consider recommending 7 days of backup contraception during the transition.

Current Availability Picture

As of early 2026:

  • FDA shortage status: Not listed
  • ASHP shortage status: Not listed
  • Pharmacy stocking: Variable — chain pharmacies often don't carry it; independent pharmacies may be more flexible
  • Wholesaler availability: Generally available through major wholesalers, but may require special ordering

The disconnect between "available from the manufacturer" and "on pharmacy shelves" is the primary patient barrier.

Cost and Access

Understanding the cost landscape helps when counseling patients:

  • Cash price: $35–$45 per 28-day pack
  • With discount card (SingleCare): As low as $11.88 per pack
  • Insurance coverage: Varies by plan. Under the ACA, most plans must cover at least one contraceptive per category at $0 cost-sharing. Turqoz may or may not be the preferred agent on a given formulary.
  • Prior authorization: Some plans may require PA or step therapy (trying a preferred brand first)

For patients facing cost barriers, refer them to our guide on saving money on Turqoz 28 Day.

Tools and Resources for Providers

Several tools can help you and your care team support patients who are struggling to find Turqoz:

Medfinder for Providers

Medfinder offers real-time pharmacy stock checking, allowing your staff to verify which nearby pharmacies have Turqoz in stock before sending a prescription. This can prevent the frustrating cycle of rejected fills and pharmacy transfers.

Lupin Pharmaceuticals Direct

For supply questions, providers can contact Lupin at 1-800-399-2561 or visit lupinpharmaceuticals.com for distribution and availability information.

Patient Assistance Programs

For uninsured or underinsured patients:

  • NeedyMeds (needymeds.org) — searchable database of assistance programs
  • RxAssist (rxassist.org) — comprehensive patient assistance directory
  • SingleCare/GoodRx — free discount cards that can reduce cash price to $12–$15

Looking Ahead

Several trends may improve Turqoz accessibility over time:

  • Generic entry: When patent exclusivity expires, generic norgestrel/ethinyl estradiol products may enter the market, significantly improving availability and reducing cost
  • Formulary expansion: As prescribing volume grows, PBMs are more likely to add Turqoz to preferred formularies
  • Pharmacy stocking: Increased demand naturally leads to more pharmacies carrying the product

In the meantime, prescribers play a critical role in managing patient expectations and providing seamless transitions to alternative contraceptives when needed.

Final Thoughts

Turqoz 28 Day is not in a formal shortage, but its real-world availability remains inconsistent in 2026. As a prescriber, you can make a significant difference by:

  1. Proactively discussing availability with patients before they leave your office
  2. Having 1–2 backup COC options ready to prescribe
  3. Directing patients and staff to Medfinder for Providers for real-time stock checks
  4. Ensuring patients understand the importance of not missing pills during supply disruptions

For a practical step-by-step workflow, see our companion article: How to help your patients find Turqoz 28 Day in stock.

Is Turqoz 28 Day AB-rated to any other oral contraceptive?

No. Turqoz (norgestrel/ethinyl estradiol 0.3 mg/0.03 mg) is not AB-rated to any other combined oral contraceptive. Pharmacists cannot automatically substitute another product without a new prescription from the provider.

What is the closest therapeutic alternative to Turqoz 28 Day?

Levonorgestrel/ethinyl estradiol combinations are the closest pharmacologic match, since norgestrel is a racemic mixture that includes levonorgestrel. Generics of Nordette or Levlen-type products are widely available alternatives.

Should I write a backup prescription when prescribing Turqoz?

It's a good practice. Given Turqoz's inconsistent pharmacy availability, writing a backup prescription for a widely available COC generic (such as norgestimate/ethinyl estradiol) gives patients a fallback if their pharmacy can't fill the Turqoz Rx.

How can my practice check Turqoz availability before sending a prescription?

Use Medfinder for Providers (medfinder.com/providers) to check real-time pharmacy stock. Your staff can verify availability before sending the electronic prescription, reducing rejected fills and patient frustration.

Why waste time calling, coordinating, and hunting?

You focus on staying healthy. We'll handle the rest.

Try Medfinder Concierge Free

Medfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.

25,000+ have already found their meds with Medfinder.

Start your search today.
      What med are you looking for?
⊙  Find Your Meds
99% success rate
Fast-turnaround time
Never call another pharmacy